Effect of Combined Exercise Post-treatment Intervention in Lean Mass Recovery in Breast Cancer Survival. (WIM1)
Sarcopenic Obesity in Breast Cancer Survival, Muscle Strength Quantitative Trait Locus 1, Cardiopulmonary Capacity
About this trial
This is an interventional treatment trial for Sarcopenic Obesity in Breast Cancer Survival focused on measuring Physical treatment, Exercise prescription to breast cancer survival, Side cancer effect treatment
Eligibility Criteria
Inclusion Criteria:
- Breast cancer diagnosed confirmed stage I-IIIA.
- Randomized disposition.
- Minimum of forty-five days and maximum of thirty-six months after finishing treatments (chemotherapy and radiotherapy).
- 0-1 in Eastern Cooperative Oncology Group (ECOG) scale (present the ability to walk briskly)
- Oncologist approval.
- Informed Consent signed.
- Community of Madrid inhabitant.
Exclusion Criteria:
- Metastasis presence
- Serious medical risk such as unstable cardiac condition or severe pulmonary disease and anticoagulants treatments.
- Oncology or primary care approval who verified the medical risk exclusion criteria.
- ECOG > 1
- Pregnant
Sites / Locations
- Physical Activity and Sport Science FacultyRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control Group
Physical Intervention Group
Patients in this group will be asked to maintain the same activity level until the baseline assessments. They cannot change physical activity and nutritional habits.
They have to perform two days per week of guide and planned exercise during three months. All classes are composed by different parts: aerobic exercise, to improve cardiovascular capacity, strength, to work muscle mass and flexibility to increase joint movements. They have to present an attendance above or equal to 80%.